Interventions for sexual problems following treatment for breast cancer: a systematic review Sally TaylorClare HarleyGalina Velikova Review 09 September 2011 Pages: 711 - 724
Impact of mammographic screening on the detection of good and poor prognosis breast cancers Laura J. EssermanYiwey ShiehLaura J. van ’t Veer Review 04 September 2011 Pages: 725 - 734
MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes Clemens L. BockmeyerMatthias ChristgenUlrich Lehmann Preclinical study 17 March 2011 Pages: 735 - 745
β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines Kelley S. MaddenMercedes J. SzpunarEdward B. Brown Preclinical study 14 January 2011 Pages: 747 - 758
Membrane localization of insulin receptor substrate-2 (IRS-2) is associated with decreased overall survival in breast cancer Jennifer L. ClarkKaren DresserLeslie M. Shaw Preclinical study 22 January 2011 Pages: 759 - 772
Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice Peter W. H. FringsCatharina H. M. J. Van ElssenMichel van Gelder Preclinical study 28 January 2011 Pages: 773 - 781
Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo Antje SchubertThomas HawighorstCarsten Gründker Preclinical study 30 January 2011 Pages: 783 - 790
Differential expression of arrestins is a predictor of breast cancer progression and survival Allison M. MichalAmy R. PeckJeffrey L. Benovic Preclinical study 12 February 2011 Pages: 791 - 807
The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature Shu ZhaoYupeng LiuMaopeng Yang Preclinical study 11 February 2011 Pages: 809 - 816
Erratum to: The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature Shu ZhaoYupeng LiuMaopeng Yang Erratum 08 July 2011 Pages: 817 - 817
Predictive value of BI-RADS classification for breast imaging in women under age 50 Gannon KennedyMatthew MarkertEli Avisar Clinical Trial 12 July 2011 Pages: 819 - 823
Dose-dense doxorubicin and cyclophosphamide followed by dose-dense albumin-bound paclitaxel plus bevacizumab is safe as adjuvant therapy in patients with early stage breast cancer John PippenDevchand PaulJose Iglesias Clinical Trial 06 October 2011 Pages: 825 - 831
Molecular detection of breast cancer metastasis in sentinel lymph nodes by reverse transcriptase polymerase chain reaction (RT-PCR): identifying, evaluating and establishing multi-marker panels Christian W. WallwienerMarkus WallwienerTanja N. Fehm Clinical Trial 21 August 2011 Pages: 833 - 844
Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer Alexandre CochetGaetan QuilichiniFrançois Brunotte Clinical trial 15 September 2011 Pages: 845 - 854
Survival-adjusted health-related quality of life (HRQL) among patients with metastatic breast cancer receiving paclitaxel plus bevacizumab versus paclitaxel alone: results from Eastern Cooperative Oncology Group Study 2100 (E2100) David CellaMolin WangKathy Miller Clinical Trial 27 August 2011 Pages: 855 - 861
Effects of zoledronic acid on bone mineral density during aromatase inhibitor treatment of Korean postmenopausal breast cancer patients Seung Ah LeeSeung Hyun HwangHy-De Lee Clinical Trial 23 August 2011 Pages: 863 - 870
Invasive lobular carcinoma: response to neoadjuvant letrozole therapy J. Michael DixonLorna RenshawJeremy Thomas Clinical Trial 26 August 2011 Pages: 871 - 877
Soy intake in association with menopausal symptoms during the first 6 and 36 months after breast cancer diagnosis Tsogzolmaa DorjgochooKai GuXiao Ou Shu Epidemiology 12 August 2010 Pages: 879 - 889
Erratum to: Soy intake in association with menopausal symptoms during the first 6 and 36 months after breast cancer diagnosis Tsogzolmaa DorjgochooKai GuXiao Ou Shu Erratum 02 February 2011 Pages: 891 - 896
The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers A. M. BrewsterC. EtzelR. L. Theriault Epidemiology 02 August 2011 Pages: 897 - 904
Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome Hong ShiMelanie BevierAsta Försti Epidemiology 01 June 2011 Pages: 905 - 916
Birth weight and other prenatal factors and risk of breast cancer in Asian-Americans Anna H. WuRoberta McKean-CowdinChiu-Chen Tseng Epidemiology 28 June 2011 Pages: 917 - 925
Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO) Julie LecarpentierCatherine NoguèsNadine Andrieu Epidemiology 15 July 2011 Pages: 927 - 938
Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case–control study in Korea Hyuna SungKyoung-Mu LeeDaehee Kang Epidemiology 16 July 2011 Pages: 939 - 951
The effect of delays in treatment for breast cancer metastasis on survival Su Yon JungSusan M. SereikaMargaret Rosenzweig Epidemiology 08 July 2011 Pages: 953 - 964
Childhood factors associated with mammographic density in adult women Virginia LopeBeatriz Pérez-GómezDDM Spain Epidemiology 12 July 2011 Pages: 965 - 974
Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis S. Warren AndersenP. A. NewcombA. Trentham-Dietz Epidemiology 19 July 2011 Pages: 975 - 980
Risk factors for lymphedema in breast cancer survivors, the Iowa Women’s Health Study Rehana L. AhmedKathryn H. SchmitzAaron R. Folsom Epidemiology 15 July 2011 Pages: 981 - 991
Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221) Lara E. SuchestonHua ZhaoChristine B. Ambrosone Epidemiology 16 July 2011 Pages: 993 - 1002
Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility Mikko VuorelaKatri PylkäsRobert Winqvist Epidemiology 13 July 2011 Pages: 1003 - 1010
Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore Woon-Puay KohDavid Van Den BergMimi C. Yu Epidemiology 21 July 2011 Pages: 1011 - 1019
Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer Rosa LandwehrNatalia V. BogdanovaThilo Dörk Epidemiology 31 July 2011 Pages: 1021 - 1028
Serum CD44 levels and overall survival in patients with HER2-positive breast cancer Jong-Min BaekQuanri JinFrancisco J. Esteva Epidemiology 10 August 2011 Pages: 1029 - 1036
Coexistence of breast cancer and tuberculosis in axillary lymph nodes: a case report and literature review Sami AkbulutNilgun SogutcuYusuf Yagmur Brief Report 22 September 2011 Pages: 1037 - 1042
FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer Daniel J. ParkFabrice A. OdefreyMelissa C. Southey Brief Report 21 August 2011 Pages: 1043 - 1049
BRCA1 R71K missense mutation contributes to cancer predisposition by increasing alternative transcript levels Liying ZhangLishi ChenKenneth Offit Brief Report 24 August 2011 Pages: 1051 - 1056
Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families S. L. HarveyR. L. MilneK. A. Phillips Brief Report 18 August 2011 Pages: 1057 - 1061
Vascular proliferation is increased in basal-like breast cancer Hawa NalwogaJarle B. ArnesLars A. Akslen Brief Report 28 August 2011 Pages: 1063 - 1071
Need for clarification of data in the recent meta-analysis about TGFBR1*6A/9A polymorphism and breast cancer risk Ying Zhang Letter to the Editor 11 October 2011 Pages: 1073 - 1074
